Versatope Therapeutics

United States
Arlington Heights, Illinois, United States, 01852

Company profile

Versatope Therapeutics company profile

Versatope is an immuno-therapeutic company that uses a biotechnology platform to delivery immunity. The company develops a bacterial factory nano particle technology and multiple epitopes can be displayed to overcome strain-specific immunity, enabling biotechnology companies to develop a single vaccine to protect against multiple strains of influenza.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2017-01-01, Year

Headquarters

Postal code
01852
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding rounds
7
Total equity funding
$193,000
Last funding
Grant / $200,000 / 2025-05-16
Last equity funding
Undisclosed / $193,000
Investors
4
Lead investors
2
Founders
1
Articles
9

Founders and investors

Founders

Christopher Locher

Lead investors

MassVenturesNational Institute of Allergy and Infectious Diseases

Investors

Massachusetts Life Sciences CenterMassChallengeMassVenturesNational Institute of Allergy and Infectious Diseases